Premières mentions et répartition de la Salamandre sombre du Nord, Desmognathus fuscus, sur la rive nord du fleuve Saint-Laurent, au Québec

La Salamandre sombre du Nord (Desmognathus fuscus) est une espèce qui a fait l’objet de plusieurs inventaires au Québec étant donné qu’elle y est à la limite nord de sa répartition. Nous rapportons les premières observations de cette espèce au nord du fleuve Saint-Laurent, depuis Trois-Rivières, à l’ouest, jusqu’à Cap-Tourmente, vers l’est. Ces mentions ont été faites de 1987 à 2003, dans 20 sites. La majorité des sites où fut découverte la Salamandre sombre du Nord sont des ruisseaux et des résurgences d’eau

Découverte de la Salamandre à quatre orteils, Hemidactylium scutatum, à Québec, Québec : limite nord-est de l'espèce sur la rive nord du fleuve Saint-Laurent

En 1999 trois spécimens de Salamandre à quatre orteils ont été observés à Québec, sur la rive nord du fleuve Saint-Laurent. Des recherches effectuées au même site en 2001 ont permis de découvrir d’autres spécimens de même que des pontes. Ces mentions élargissent la distribution connue de l’espèce de 90 km vers le nord-est-est et 80 km vers le nord-nord-ouest. Il s’agit vraisemblablement de la limite nord-est de cette salamandre, sur la rive nord du Saint-Laurent.In 1999, three Four-toed Salamanders were observed at Québec, north shore of the St. Lawrence River. Field searches in 2001 allowed the discovery of another specimen as well as egg clutches. These records extend the known range of the species 90 km north-east-east and 80 km north-north-west. This is probably the northeastern limit of this salamander’s range on the north shore of St. Lawrence River

Correction of megavoltage cone-beam CT images of the pelvic region based on phantom measurements for dose calculation purposes.

Megavoltage cone-beam CT (MVCBCT) is an imaging technology that provides a 3D representation of the patient in treatment position. Because it is a form of x-ray tomography, MVCBCT images give information about the attenuation coefficients of the imaged tissues, and thus could be used for dose calculation. However, the cupping and missing data artifacts seen on MVCBCT images can cause inaccuracies in dose calculations. To eliminate these inaccuracies, a correction method specific to pelvis imaging and based on phantom measurements has been devised. Pelvis-shaped water phantoms of three different sizes were designed and imaged with MVCBCT. Three sets of correction factors were created from the artifacts observed in these MVCBCT images by dividing the measured CT number by the predefined CT number for water. Linear interpolation is performed between the sets of correction factors to take into account the varying size of different patients. To compensate for the missing anatomy due to the limited field of view of the MVCBCT system, the MVCBCT image is complemented with the kilovoltage CT (kVCT) image acquired for treatment planning.When the correction method is applied to an anthropomorphic pelvis phantom, the standard deviation between dose calculations performed with kVCT and MVCBCT images is 0.6%, with 98% of the dose points agreeing within +/- 3%.With uncorrected MVCBCT images this percentage falls to 75%. An example of dose calculation performed with a corrected clinicalMVCBCT image of a prostate cancer patient shows that changes in anatomy of normal tissues result in variation of the dose distribution received by these tissues.This correction method enablesMVCBCT images to be used for the verification of the daily dose distribution for patients treated in the pelvis region

P-glycoprotein of blood brain barrier: cross-reactivity of MAb C219 with a 190 kDa protein in bovine and rat isolated brain capillaries

AbstractP-glycoprotein (P-gp), an active efflux pump of antitumor drugs, is strongly expressed in endothelial cells of the blood brain barrier (BBB). Two proteins (155 and 190 kDa) were detected by Western blot analysis of beef and rat capillaries with the monoclonal antibody (MAb) C219. In order to characterize the nature of these proteins, their profile of solubilization by different detergents was established and compared with that of P-gp from the CHRC5 tumoral cell line. The 155 kDa protein (p155) of capillaries and the P-gp of CHRC5 cells were well solubilized by deoxycholate and Elugent, whereas the 190 kDa protein (p190) was only solubilized by sodium dodecylsulfate (SDS). Both proteins have different patterns of extraction by Triton X-114, p155 partitioning as a membrane protein, while p190 was insoluble. Deglycosylation of capillary proteins resulted in a 27–28 kDa decrease in the apparent molecular weight of p155, similar to that observed for the P-gp of CHRC5 cells, but a decrease of only 7–8 for p190. Only p155 was immunoprecipitated by MAb C219. These results suggest that only p155 is the P-gp in BBB and that MAb C219 cross-reacts with a 190 kDa MDR-unrelated glycosylated protein. Consequently, the use of this antibody, which is frequently used to detect P-gp in tumors, could be a pitfall of immunohistochemistry screening for cancer tissues and lead to false positive in the diagnosis of MDR

Dihydrochalcone derivatives from Populus balsamifera L. buds for the treatment of psoriasis

Psoriasis is a skin disorder characterized by epidermal hyperplasia, hyperkeratosis, and inflammation. The treatments currently available on the market only improve patients’ quality of life and are associated with undesirable side effects. Thus, research leading to the development of new, effective, and safer therapeutic agents is still relevant. Populus balsamifera L. buds were used traditionally by Native Americans to treat various skin pathologies such as eczema and psoriasis. In this study, the antipsoriatic activities of dihydrochalcone derivatives from Populus balsamifera L. buds, known as balsacones, were investigated. The experiments were performed in vitro using a psoriatic skin substitute model. Also, anti-inflammatory and antioxidant activities were investigated. The tested balsacones showed promising antipsoriatic properties by slowing down cell growth and by regulating the expression of involucrin, loricrin, and Ki67 better than methotrexate in psoriatic substitutes. All five tested compounds could be an effective topical treatment for psoriasis, with promising anti-inflammatory and antioxidant actions that may contribute to clinical improvement in patients with psoriasis

Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity

<p>Abstract</p> <p>Background</p> <p>Integrins are known to be important contributors to cancer progression. We have previously shown that the integrin β4 subunit is up-regulated in primary colon cancer. Its partner, the integrin α6 subunit, exists as two different mRNA splice variants, α6A and α6B, that differ in their cytoplasmic domains but evidence for distinct biological functions of these α6 splice variants is still lacking.</p> <p>Methods</p> <p>In this work, we first analyzed the expression of integrin α6A and α6B at the protein and transcript levels in normal human colonic cells as well as colorectal adenocarcinoma cells from both primary tumors and established cell lines. Then, using forced expression experiments, we investigated the effect of α6A and α6B on the regulation of cell proliferation in a colon cancer cell line.</p> <p>Results</p> <p>Using variant-specific antibodies, we observed that α6A and α6B are differentially expressed both within the normal adult colonic epithelium and between normal and diseased colonic tissues. Proliferative cells located in the lower half of the glands were found to predominantly express α6A, while the differentiated and quiescent colonocytes in the upper half of the glands and surface epithelium expressed α6B. A relative decrease of α6B expression was also identified in primary colon tumors and adenocarcinoma cell lines suggesting that the α6A/α6B ratios may be linked to the proliferative status of colonic cells. Additional studies in colon cancer cells showed that experimentally restoring the α6A/α6B balance in favor of α6B caused a decrease in cellular S-phase entry and repressed the activity of c-Myc.</p> <p>Conclusion</p> <p>The findings that the α6Bβ4 integrin is expressed in quiescent normal colonic cells and is significantly down-regulated in colon cancer cells relative to its α6Aβ4 counterpart are consistent with the anti-proliferative influence and inhibitory effect on c-Myc activity identified for this α6Bβ4 integrin. Taken together, these findings point out the importance of integrin variant expression in colon cancer cell biology.</p

L'appoint

Publ. dans le vol. 5, no 2, févr. 1996 de la revue L'Appoin

Mines et travaux de chantier : conduite de machinerie lourde en voirie forestière : programme d'études,5273 /

Glossaire: p.

Électrotechnique : technologie physique : programme d'études, 244.A0 /

La couv. porte en outre: La formation professionnelle et techniqueGlossaire: p. 3-

La formation professionnelle et technique

La couv. porte en outre: La formation professionnelle et techniqu